Statistics for MariMed (id:11240 MRMD)

Valuation metrics

Market cap

64.82M

Enterprise value

161.62M

Trailing P/E (ttm)

16.00

Forward P/E

-17.00

PEG ratio

-17.00

Price/Sales (ttm)

0.41

Price/Book (mrq)

0.93

Enterprise Value/Revenue

1.02

Enterprise Value/EBITDA

9.00

Overview

Shares outstanding

381.31M

Float

341.85M

Shares short

% Held by insiders

0.14%

% Held by institutions

0.01%

Average volume (10 days)

664.09K

Average volume (90 days)

Price summary

52-Week low

0.14

52-Week high

0.39

52-Week change

-100.66%

Beta

2.80

50-Day moving average

0.16

200-Day moving average

0.22

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-8.95%

Operating margin

4.22%

Operational effectiveness

Return on assets

2.35%

Return on equity

-15.15%

Income statement

Revenue (ttm)

0.42

Revenue per share (ttm)

0.42

Quarterly revenue growth (yoy)

Gross profit (ttm)

65.92M

EBITDA

18.04M

Net income to common (ttm)

-14,129,000.00

Diluted EPS (ttm)

-0.03

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

9.79M

Total cash per share (mrq)

0.03

Total debt (mrq)

89.44M

Total Debt/Equity (mrq)

102.99

Current ratio (mrq)

127.10%

Book value per share (mrq)

0.18

Cash flow

Cash flow statement

10.43M

Levered free cash flow (LFCF)

-4,755,875.00